SUBSCRIBERS

Actelion re-enters transaction talks with Johnson & Johnson

Published Thu, Dec 22, 2016 · 09:50 PM

Frankfurt

SWISS biotech company Actelion has turned back to prospective bidder Johnson & Johnson (J&J) for exclusive talks about a "strategic transaction", in an about-turn that appears to sideline rival suitor Sanofi.

Actelion said in a brief statement on Wednesday that it was in exclusive negotiations with the US health care giant but that there could be "no assurance…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes

Consumer & Healthcare

Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Billionaires selling cheap stuff get richer from inflation pain
Amazon to push cashierless shopping tech into more third-party stores, while backing off itself
Japan’s Uniqlo opens Rome store as part of European expansion
Abbott beats quarterly profit estimates on strong medical device sales

Companies & Markets

Actelion re-enters transaction talks with Johnson & Johnson

Consumer & Healthcare

Swiss watch exports plunge as China and Hong Kong demand dries up

Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO

Billionaires selling cheap stuff get richer from inflation pain

Amazon to push cashierless shopping tech into more third-party stores, while backing off itself

Japan’s Uniqlo opens Rome store as part of European expansion

Abbott beats quarterly profit estimates on strong medical device sales

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

SECTIONS

LIFESTYLE

Follow BT